-
effectivehealthcare.ahrq.gov/sites/default/files/Guidelines-Peer-Public-Review.pdf
November 08, 2013 - visibility of their or their associates’
work; suggestions must be based on valid academic or technological reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
April 01, 2022 - A list of articles excluded at full-text review, along
with reasons for exclusion, is available in Appendix
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - A list of articles
excluded at full-text review, along with reasons for exclusion, is available in Appendix
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
June 01, 2022 - report periods is
provided in Appendix C and a list of articles excluded at full text, along with reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
April 01, 2022 - A list of articles excluded at full-text review, along
with reasons for exclusion, is available in Appendix
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-2-acute-pain.pdf
May 01, 2022 - for this update is provided in Appendix C and a list of
articles excluded at full text, along with reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
November 26, 2024 - This includes:
• Who misuses prescription stimulants, and what are the reasons for misuse? … We will maintain a record of studies
excluded at the full-text level with reasons for exclusion. … The assessment will clearly document uncertainty, outline the reasons for
insufficient evidence where
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - for this update is provided in Appendix C and a list of
articles excluded at full text, along with reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - list of studies excluded after reviewing the full manuscripts can
be found in Appendix I along with reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
April 15, 2021 - It would also be
helpful to describe the reasons that the evidence was
insufficient in the context … We also
state that inconsistency and study
limitations were reasons for the insufficient
rating. … At the end of the first paragraph, it would be useful to
be more specific about the reasons that the … We have added explanations of precision
and reasons for grades in several parts of
the report. … For
these reasons, we would suggest careful review of the
document organization.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - For the discontinued studies, were there reasons given for discontinuation? … Reasons for delays (if any)
Population Total enrollment, sample size in each arm, drop-outs
Participants … ClinicalTrials.gov that were not completed or discontinued:
a.For the discontinued studies, were there reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
February 01, 2025 - Systematic Review Search Strategy Development Tools: A Practical Guide for Expert Searchers
Research White Paper
Systematic Review Search Strategy Development
Tools: A Practical Guide for Expert Searchers
White Paper
Systematic Review Search Strategy Development
Tools: A Practical Guide for Expert Se…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - list of studies excluded after reviewing the full manuscripts can be found in
Appendix I along with reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
June 01, 2011 - Team members could differ on the
relative importance of these reasons. … * Reasons for Gap:
A. Insufficient or imprecise information
B. Biased information
C. … These reasons were: A. insufficient
information and C. unknown consistency. … Team members could differ on the
relative importance of these reasons. … Decisions on the relative importance of these reasons are
often arbitrary.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
January 01, 2009 - recognition
and management, and noninvasive diagnosis of CAD in women is particularly challenging for many
reasons
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
April 01, 2024 - List of Excluded Studies with Reasons Upon Full-Text Review
5
Making Healthcare Safer IV – … Appendix D contains a list of studies excluded
after full text review and reasons for exclusion. … List of Excluded Studies With Reasons Upon
Full-Text Review
1.
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-hospitalizations/research
-
effectivehealthcare.ahrq.gov/sites/default/files/mccullough.pdf
January 01, 2011 - McCullough
Slide
1: An Ethical Framework for Supporting
Shared Decision Making
When Clinical
Evidence is Low
Laurence B. McCullough, Ph.D.
Dalton Tomlin Chair in Medical Ethics and Health Policy
Associate Director for Education
Center for Medical Ethics and
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0399_01-07-2011.pdf
January 01, 2011 - Does the comparative effectiveness vary when lesions are unresectable due to
anatomic reasons compared
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
January 01, 2010 - Trial data may be insufficient for a number of reasons:
Population: may not be available for subpopulations … selection bias
Occurs when different diagnoses, severity of illness, or comorbid conditions are important reasons … groups differ because different diagnoses, severity of illness, or comorbid conditions are important reasons … However, relying solely on RCTs to evaluate harms in CERs is problematic for a number of reasons. … Trials To Assess Harms (III)
Using Randomized Controlled Trials To Assess Harms (III)
Despite the reasons